Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2026-03-09 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于控股股东之一致行动人增持公司股份计划的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding a plan by a controlling shareholder's concert party to increase their shareholding in the company. It details the intent, amount, timing, and risks of the planned share purchase. There is no financial data, earnings information, or report attached or referenced as being published. The document is a formal disclosure of a shareholding increase plan by a major shareholder, which fits the category of Major Shareholding Notification (MRQ). The document length is short (1664 characters), and it is not a report publication announcement or regulatory filing. Therefore, the classification is MRQ with high confidence.
2026-03-09 Chinese
关于子公司重大诉讼的公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement regarding a significant litigation involving a controlling subsidiary of the company. It details the lawsuit's status, parties involved, claims, and potential financial impact but does not contain financial statements or detailed financial analysis. The document is a formal legal proceeding update rather than a full legal proceeding report or financial report. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is short and focused on litigation information, not a full annual or interim report or audit report.
2026-02-06 Chinese
2025年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2025 annual performance forecast (业绩预告) for the company 古汉医药集团股份公司. It provides estimated net profit figures for the full fiscal year 2025, including a range of expected losses and explanations for the changes. It explicitly states that the financial data have not been audited yet and that the final audited data will be disclosed in the 2025 annual report. The document is short (979 characters) and serves as a preliminary earnings forecast rather than a full financial report. This type of document is best classified as an Earnings Release (ER), which covers initial announcements of quarterly or periodical financial results or forecasts with key highlights only. FY 2025
2026-01-29 Chinese
湖南启元律师事务所关于古汉医药集团股份公司2026年第一次临时股东会的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and results of the 2026 first extraordinary general meeting (临时股东会) of shareholders of a company. It details the legality and validity of the meeting's notice, attendance, voting procedures, and results. It does not contain financial statements or management discussion but focuses on the legal compliance of the shareholder meeting process. This type of document is a legal proceedings report related to corporate governance and shareholder meetings, not an annual report, earnings release, or proxy solicitation. Therefore, it fits best under Legal Proceedings Report (LTR). The document length is 2739 characters, which is relatively short but contains substantive legal opinion content, not just an announcement or certification, so it is not RPA or RNS.
2026-01-16 Chinese
2026年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the 2026 first extraordinary shareholders' meeting of the company 古汉医药集团股份公司. It details the meeting date, voting methods, attendance, voting results on a specific proposal, and legal opinions confirming the meeting's legality and validity. There is no financial data or report content, only the announcement of the meeting's resolutions and voting outcomes. The document length is short (1975 characters) and it serves as an official announcement of voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-01-16 Chinese
关于变更签字注册会计师的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the change of the signing certified public accountant (CPA) for the company's 2025 financial report audit. It details the personnel changes within the auditing firm and assures that the change will not affect the audit quality. The document references prior announcements and includes information about the new signing CPA's qualifications and independence. The document length is short (1120 characters) and it is clearly an announcement about a change in audit personnel rather than the audit report itself or the full annual report. Therefore, it fits best under Audit Report / Information (AR), which covers standalone audit reports and related audit information excluding full annual reports. FY 2025
2026-01-16 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.